Aug 6, 2024 04:05PM
Jul 15, 2024 08:00AM
Jul 2, 2024 08:00AM
Jan 8, 2024 05:23AM
Jan 7, 2024 05:00PM
Nov 14, 2023 04:05PM
Aug 14, 2023 04:05PM Heron Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Updates
May 11, 2023 04:01PM
Apr 20, 2023 09:00AM
Mar 23, 2023 04:05PM
Aug 9, 2022 08:01AM
Aug 9, 2022 08:01AM
Aug 9, 2022 08:00AM
Jun 30, 2022 08:31AM Heron Therapeutics (HRTX) Announces Restructuring and Cost Reduction Plan to Address Market Dynamics
Jun 30, 2022 08:30AM
May 9, 2022 04:05PM
Mar 1, 2022 06:54AM
Feb 28, 2022 04:05PM
May 10, 2021 11:55AM
May 10, 2021 08:30AM
Feb 24, 2021 08:30AM Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2020 and Highlights Recent Corporate Updates
Jan 21, 2021 08:34AM
Jan 21, 2021 08:30AM
Jan 11, 2021 08:30AM
Jun 4, 2020 09:03AM
Jun 4, 2020 09:00AM
May 18, 2020 09:06AM
May 18, 2020 09:00AM Heron Therapeutics Announces Initiation of Phase 1b/2 Clinical Study of HTX-034 for the Treatment of Postoperative Pain
May 6, 2020 09:00AM
Mar 2, 2020 07:30AM
Feb 20, 2020 09:19AM
Feb 20, 2020 09:16AM
Feb 20, 2020 07:14AM
Feb 19, 2020 04:05PM
Jan 13, 2020 08:37AM Heron Therapeutics (HRTX) Highlights Progress in Pain Management and CINV Franchises
Jan 13, 2020 08:30AM
Dec 16, 2019 04:06PM
Dec 16, 2019 04:05PM
Dec 3, 2019 07:33AM
Dec 3, 2019 07:30AM
Nov 12, 2019 08:30AM
Oct 28, 2019 08:32AM Heron Therapeutics (HRTX) Announces FDA Acceptance of NDA Resubmission for HTX-011 for Management of Postoperative Pain
Oct 28, 2019 08:30AM
Oct 1, 2019 09:38AM
Apr 22, 2019 02:47PM
Apr 1, 2019 08:32AM
Apr 1, 2019 08:30AM
Mar 11, 2019 08:30AM
Mar 6, 2019 03:03PM Bullish Options Positioning in Heron Therapeutics (HRTX) Targets Upside Through May Ahead of HTX-011 PDUFA Review Apr. 30th Due Date -Susquehanna
Feb 22, 2019 08:30AM

14,982 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All